483 Glenmark Pharmaceuticals Feb 2016

483 Glenmark Pharmaceuticals Feb 2016

Yasamin Ameri FDA$119.00 - Available Now

FDA investigators audited the Glenmark Pharmaceuticals - Pithampur, Dhar, India facility and issued 3 inspectional observations (via FDA 483) on 26 Feb 2016.

Product details

  • Category: Human Drugs
  • Number of Observations: 3
  • Inspection end: 26 Feb 2016
  • Location: Pithampur, Dhar, India
  • FEI: 3008565058
Add To Cart